Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3TR-SLE1 Flare Biomarker Study
NCT05458622Phase 3Active, not recruiting
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Nov 2022
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by Centre Hospitalier Universitaire de Brest. Primary endpoint: Flare patient proportion according to the BILAG index at 24 months. Started Nov 2022; status: active, not recruiting.
Beyond the preview
Go deeper on NCT05458622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05458622.